These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 218497)

  • 21. [IFN production by Epstein-Barr virus in human mononuclear leukocytes and suppression of the virus-induced transformation by the endogenous interferon].
    Kikuta H
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):46-57. PubMed ID: 3009290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.
    Doetsch PW; Suhadolnik RJ; Sawada Y; Mosca JD; Flick MB; Reichenbach NL; Dang AQ; Wu JM; Charubala R; Pfleiderer W; Henderson EE
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6699-703. PubMed ID: 6171822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation.
    Gross TG; Volsky DJ
    Virology; 1984 Feb; 133(1):211-5. PubMed ID: 6322431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
    Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular Epstein-Barr virus genomes of reduced size in a human lymphoid cell line of infectious mononucleosis origin.
    Adams A; Bjursell G; Kaschka-Dierich C; Lindahl T
    J Virol; 1977 May; 22(2):373-80. PubMed ID: 194059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of human leukocytes with Epstein-Barr virus after cellular exposure to chemical or physical mutagens.
    Henderson EE; Ribecky R
    J Natl Cancer Inst; 1980 Jan; 64(1):33-9. PubMed ID: 6243375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incorporation of 5-iodo-5'-amino-2',5-dideoxyuridine and 5-iodo-2'-deoxyuridine into herpes simplex virus DNA. Relationship between antiviral activity and effects on DNA structure.
    Fischer PH; Chen MS; Prusoff WH
    Biochim Biophys Acta; 1980 Feb; 606(2):236-45. PubMed ID: 6243982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference.
    Miller G; Robinson J; Heston L; Lipman M
    IARC Sci Publ (1971); 1975; (11 Pt 1):395-408. PubMed ID: 190145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on chemical carcinogen enhancement of Epstein-Barr virus induced transformation of human neonatal and adult peripheral blood lymphocytes.
    Henderson EE; Fronko G
    Int J Cancer; 1984 Mar; 33(3):331-8. PubMed ID: 6321362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantitative analysis of the susceptibility of human leukocytes to transformation by Epstein-Barr virus.
    Katsuki T; Hinuma Y
    Int J Cancer; 1976 Jul; 18(1):7-13. PubMed ID: 181337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant lymphoma induction in rabbits by intravenous inoculation of Epstein-Barr-virus-related herpesvirus from HTLV-II-transformed cynomolgus leukocyte cell line (Si-IIA).
    Hayashi K; Koirala TR; Ino H; Chen HL; Ohara N; Teramoto N; Yoshino T; Takahashi K; Yamada M; Nii S
    Int J Cancer; 1995 Dec; 63(6):872-80. PubMed ID: 8847148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase.
    Sixbey JW; Pagano JS
    J Virol; 1985 Jan; 53(1):299-301. PubMed ID: 2981351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo.
    Herrold RE; Marchini A; Fruehling S; Longnecker R
    J Virol; 1996 Mar; 70(3):2049-54. PubMed ID: 8627735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The transforming prototype of Epstein-Barr virus (B95-8) is also a lytic virus.
    Glaser R; Tarr KL; Dangel AW
    Int J Cancer; 1989 Jul; 44(1):95-100. PubMed ID: 2545637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha.
    Garner JG; Hirsch MS; Schooley RT
    Infect Immun; 1984 Mar; 43(3):920-4. PubMed ID: 6321354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus.
    Lucas KG; Burton R; Heilman DK; Pollok K; Emanuel D
    J Hematother; 1997 Dec; 6(6):587-90. PubMed ID: 9483194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F; Marchini A; Kieff E
    J Virol; 1991 Apr; 65(4):1701-9. PubMed ID: 1848303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer.
    Volsky DJ; Gross T; Sinangil F; Kuszynski C; Bartzatt R; Dambaugh T; Kieff E
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):5926-30. PubMed ID: 6091119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.